Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fertilization in Vitro | 11 | 2022 | 85 | 2.930 |
Why?
|
| Anti-Mullerian Hormone | 8 | 2025 | 66 | 2.840 |
Why?
|
| Embryo Transfer | 7 | 2022 | 25 | 2.520 |
Why?
|
| Placenta | 6 | 2022 | 61 | 1.930 |
Why?
|
| Blastocyst | 3 | 2021 | 73 | 1.790 |
Why?
|
| Follicular Fluid | 3 | 2025 | 15 | 1.760 |
Why?
|
| Infertility | 4 | 2023 | 31 | 1.550 |
Why?
|
| Cryopreservation | 2 | 2024 | 30 | 1.450 |
Why?
|
| Pregnancy Rate | 8 | 2023 | 31 | 1.430 |
Why?
|
| Oocytes | 3 | 2024 | 200 | 1.410 |
Why?
|
| Placenta Diseases | 2 | 2021 | 9 | 1.330 |
Why?
|
| Oocyte Retrieval | 5 | 2025 | 15 | 1.290 |
Why?
|
| Reproductive Techniques, Assisted | 6 | 2022 | 34 | 1.280 |
Why?
|
| Pregnancy Outcome | 6 | 2023 | 195 | 1.120 |
Why?
|
| Live Birth | 4 | 2022 | 21 | 1.100 |
Why?
|
| Pregnancy | 16 | 2024 | 2370 | 1.080 |
Why?
|
| Premature Birth | 3 | 2022 | 115 | 0.950 |
Why?
|
| Ovarian Follicle | 3 | 2025 | 39 | 0.930 |
Why?
|
| Heat-Shock Proteins | 1 | 2025 | 68 | 0.890 |
Why?
|
| Fertilization | 3 | 2021 | 82 | 0.870 |
Why?
|
| Semen | 2 | 2022 | 48 | 0.850 |
Why?
|
| Retrospective Studies | 14 | 2023 | 6726 | 0.720 |
Why?
|
| Female | 29 | 2025 | 33350 | 0.700 |
Why?
|
| Birth Weight | 5 | 2022 | 85 | 0.700 |
Why?
|
| Infertility, Male | 1 | 2021 | 57 | 0.700 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2022 | 43 | 0.700 |
Why?
|
| Semen Preservation | 1 | 2021 | 6 | 0.690 |
Why?
|
| Phthalic Acids | 1 | 2021 | 40 | 0.680 |
Why?
|
| Acetaminophen | 1 | 2021 | 57 | 0.680 |
Why?
|
| Adult | 17 | 2025 | 17116 | 0.650 |
Why?
|
| Embryo Culture Techniques | 1 | 2020 | 11 | 0.640 |
Why?
|
| Diabetes, Gestational | 1 | 2022 | 142 | 0.630 |
Why?
|
| Pain Management | 1 | 2021 | 169 | 0.600 |
Why?
|
| Embryo, Mammalian | 1 | 2019 | 156 | 0.590 |
Why?
|
| Spermatozoa | 1 | 2021 | 261 | 0.580 |
Why?
|
| Cumulus Cells | 1 | 2018 | 6 | 0.560 |
Why?
|
| In Vitro Oocyte Maturation Techniques | 1 | 2018 | 8 | 0.560 |
Why?
|
| Preconception Care | 1 | 2017 | 23 | 0.540 |
Why?
|
| Thrombosis | 1 | 2019 | 198 | 0.520 |
Why?
|
| Weight Reduction Programs | 1 | 2017 | 57 | 0.520 |
Why?
|
| Humans | 27 | 2025 | 64238 | 0.480 |
Why?
|
| Infant, Newborn | 6 | 2024 | 1375 | 0.470 |
Why?
|
| Patient Compliance | 1 | 2017 | 362 | 0.460 |
Why?
|
| Colostrum | 1 | 2014 | 6 | 0.440 |
Why?
|
| Lactation | 1 | 2014 | 70 | 0.420 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2014 | 134 | 0.400 |
Why?
|
| Ovulation Induction | 3 | 2023 | 13 | 0.390 |
Why?
|
| Congenital Abnormalities | 2 | 2024 | 25 | 0.390 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 571 | 0.350 |
Why?
|
| Abortion, Spontaneous | 3 | 2021 | 31 | 0.340 |
Why?
|
| Polycystic Ovary Syndrome | 2 | 2021 | 23 | 0.340 |
Why?
|
| Culture Media | 2 | 2022 | 79 | 0.320 |
Why?
|
| Sperm Injections, Intracytoplasmic | 2 | 2021 | 32 | 0.310 |
Why?
|
| Obesity | 1 | 2017 | 1247 | 0.310 |
Why?
|
| HIV-1 | 1 | 2014 | 723 | 0.290 |
Why?
|
| Embryo Implantation | 2 | 2018 | 21 | 0.280 |
Why?
|
| HIV Infections | 1 | 2014 | 976 | 0.260 |
Why?
|
| Young Adult | 4 | 2024 | 4776 | 0.250 |
Why?
|
| Massachusetts | 2 | 2022 | 2094 | 0.240 |
Why?
|
| Body Mass Index | 2 | 2020 | 872 | 0.230 |
Why?
|
| Cricetulus | 1 | 2025 | 100 | 0.230 |
Why?
|
| Insemination, Artificial | 2 | 2023 | 3 | 0.220 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2025 | 49 | 0.220 |
Why?
|
| CHO Cells | 1 | 2025 | 189 | 0.220 |
Why?
|
| Ovarian Reserve | 2 | 2021 | 9 | 0.220 |
Why?
|
| Cricetinae | 1 | 2025 | 368 | 0.220 |
Why?
|
| Fertility Preservation | 1 | 2024 | 11 | 0.210 |
Why?
|
| Infertility, Female | 2 | 2021 | 46 | 0.210 |
Why?
|
| Male | 8 | 2024 | 30294 | 0.210 |
Why?
|
| Leukemia | 1 | 2022 | 60 | 0.190 |
Why?
|
| Time Factors | 2 | 2021 | 3724 | 0.180 |
Why?
|
| Men | 1 | 2021 | 3 | 0.180 |
Why?
|
| Perioperative Period | 1 | 2021 | 21 | 0.180 |
Why?
|
| Mercury | 1 | 2021 | 8 | 0.180 |
Why?
|
| Placebos | 1 | 2021 | 72 | 0.180 |
Why?
|
| Administration, Intravenous | 1 | 2021 | 65 | 0.170 |
Why?
|
| Gonadotropins | 1 | 2021 | 14 | 0.170 |
Why?
|
| Semen Analysis | 1 | 2021 | 20 | 0.170 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2021 | 39 | 0.170 |
Why?
|
| Sperm Motility | 1 | 2021 | 49 | 0.170 |
Why?
|
| Weight Gain | 1 | 2022 | 168 | 0.170 |
Why?
|
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2020 | 4 | 0.170 |
Why?
|
| Anovulation | 1 | 2020 | 10 | 0.170 |
Why?
|
| Cohort Studies | 3 | 2024 | 2604 | 0.170 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2021 | 39 | 0.170 |
Why?
|
| Maternal Health | 1 | 2020 | 15 | 0.170 |
Why?
|
| Fetal Resorption | 1 | 2020 | 1 | 0.160 |
Why?
|
| Pregnancy, Twin | 1 | 2020 | 6 | 0.160 |
Why?
|
| Infant, Premature | 1 | 2022 | 184 | 0.160 |
Why?
|
| Pregnancy Complications | 1 | 2024 | 383 | 0.160 |
Why?
|
| Pain Measurement | 1 | 2021 | 348 | 0.160 |
Why?
|
| Time-Lapse Imaging | 1 | 2020 | 19 | 0.160 |
Why?
|
| Progesterone | 1 | 2020 | 163 | 0.160 |
Why?
|
| Double-Blind Method | 1 | 2021 | 744 | 0.150 |
Why?
|
| Mullerian Ducts | 1 | 2019 | 5 | 0.150 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2019 | 28 | 0.150 |
Why?
|
| Estradiol | 1 | 2020 | 258 | 0.150 |
Why?
|
| Receptors, Peptide | 1 | 2019 | 34 | 0.150 |
Why?
|
| Uterus | 1 | 2019 | 42 | 0.150 |
Why?
|
| Adolescent | 2 | 2021 | 6304 | 0.150 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 771 | 0.150 |
Why?
|
| Ambulatory Care | 1 | 2021 | 317 | 0.140 |
Why?
|
| Time-to-Pregnancy | 1 | 2017 | 3 | 0.140 |
Why?
|
| Endometrium | 1 | 2017 | 31 | 0.130 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2017 | 29 | 0.130 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 2737 | 0.120 |
Why?
|
| Weight Loss | 1 | 2017 | 273 | 0.110 |
Why?
|
| Clonal Evolution | 1 | 2014 | 6 | 0.110 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2014 | 18 | 0.110 |
Why?
|
| Mutation Rate | 1 | 2014 | 23 | 0.110 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2014 | 15 | 0.110 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2014 | 34 | 0.110 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 2014 | 28 | 0.110 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2014 | 93 | 0.110 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2014 | 46 | 0.110 |
Why?
|
| Complementarity Determining Regions | 1 | 2014 | 38 | 0.110 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 2616 | 0.110 |
Why?
|
| Antibody Formation | 1 | 2014 | 114 | 0.110 |
Why?
|
| Immunophenotyping | 1 | 2014 | 197 | 0.110 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2014 | 76 | 0.100 |
Why?
|
| Viral Load | 1 | 2014 | 233 | 0.100 |
Why?
|
| Mice | 2 | 2025 | 11003 | 0.100 |
Why?
|
| Animal Communication | 1 | 2013 | 4 | 0.100 |
Why?
|
| HIV Antibodies | 1 | 2014 | 148 | 0.100 |
Why?
|
| Animals | 5 | 2025 | 20961 | 0.100 |
Why?
|
| Smell | 1 | 2013 | 29 | 0.100 |
Why?
|
| Primates | 1 | 2013 | 55 | 0.100 |
Why?
|
| Lemuridae | 1 | 2012 | 1 | 0.100 |
Why?
|
| Scent Glands | 1 | 2012 | 1 | 0.100 |
Why?
|
| Bodily Secretions | 1 | 2012 | 1 | 0.100 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 463 | 0.090 |
Why?
|
| Immunologic Memory | 1 | 2014 | 290 | 0.090 |
Why?
|
| Neoplasms | 1 | 2022 | 1392 | 0.090 |
Why?
|
| Insemination | 2 | 2022 | 2 | 0.090 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1365 | 0.090 |
Why?
|
| Biomarkers | 1 | 2017 | 1431 | 0.090 |
Why?
|
| Biological Evolution | 1 | 2012 | 122 | 0.090 |
Why?
|
| Phenotype | 1 | 2014 | 1222 | 0.080 |
Why?
|
| Gestational Age | 2 | 2021 | 191 | 0.080 |
Why?
|
| Logistic Models | 2 | 2020 | 1270 | 0.060 |
Why?
|
| Infant | 2 | 2022 | 1664 | 0.060 |
Why?
|
| Middle Aged | 1 | 2024 | 17898 | 0.060 |
Why?
|
| Maternal Age | 1 | 2024 | 33 | 0.060 |
Why?
|
| Chorionic Gonadotropin | 1 | 2023 | 15 | 0.050 |
Why?
|
| Risk Factors | 2 | 2024 | 5339 | 0.050 |
Why?
|
| Child | 2 | 2022 | 4583 | 0.050 |
Why?
|
| Clomiphene | 1 | 2021 | 2 | 0.040 |
Why?
|
| Fertility Agents, Female | 1 | 2021 | 6 | 0.040 |
Why?
|
| Pregnancy, Multiple | 1 | 2021 | 10 | 0.040 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2021 | 85 | 0.040 |
Why?
|
| Reproduction | 1 | 2021 | 93 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 3450 | 0.040 |
Why?
|
| Ovary | 1 | 2021 | 101 | 0.040 |
Why?
|
| Individuality | 1 | 2020 | 22 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 2021 | 60 | 0.040 |
Why?
|
| Precision Medicine | 1 | 2020 | 124 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 735 | 0.040 |
Why?
|
| Fertility | 1 | 2019 | 83 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 984 | 0.030 |
Why?
|
| CD146 Antigen | 1 | 2017 | 1 | 0.030 |
Why?
|
| CD13 Antigens | 1 | 2017 | 6 | 0.030 |
Why?
|
| Embryoid Bodies | 1 | 2017 | 9 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2017 | 14 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2017 | 41 | 0.030 |
Why?
|
| Endometriosis | 1 | 2017 | 28 | 0.030 |
Why?
|
| Base Sequence | 1 | 2019 | 1332 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 1769 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 783 | 0.030 |
Why?
|
| Gene Expression | 1 | 2017 | 851 | 0.030 |
Why?
|
| Cell Line | 1 | 2017 | 2055 | 0.020 |
Why?
|
| Olfactory Perception | 1 | 2012 | 3 | 0.020 |
Why?
|
| Genitalia, Male | 1 | 2012 | 10 | 0.020 |
Why?
|
| Genitalia, Female | 1 | 2012 | 17 | 0.020 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2012 | 41 | 0.020 |
Why?
|
| Sexual Behavior, Animal | 1 | 2012 | 88 | 0.020 |
Why?
|
| Seasons | 1 | 2012 | 138 | 0.020 |
Why?
|
| Social Behavior | 1 | 2012 | 89 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 334 | 0.020 |
Why?
|
| Phylogeny | 1 | 2012 | 385 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2012 | 202 | 0.020 |
Why?
|